| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/08/2014 | CN102357201B Traditional Chinese medicine composition for treating venous injury, and preparation method and application thereof |
| 01/08/2014 | CN102293761B Percutaneous absorption patch containing antiemetic component |
| 01/08/2014 | CN102264429B Microneedle device |
| 01/08/2014 | CN102188586B Yang-tonifying and body-building capsule for improving kidney function and preparation method thereof |
| 01/08/2014 | CN102028697B Non-ionic surface active agent-containing Latanoprost eye drop and preparation method thereof |
| 01/08/2014 | CN102018714B Formulations |
| 01/08/2014 | CN101972491B Grape bunch-shaped micro-capsule system and preparation method thereof |
| 01/08/2014 | CN101917979B Formulations comprising exine shells |
| 01/08/2014 | CN101836954B Method for preparing stable xanthophyll-oil suspension |
| 01/08/2014 | CN101732672B Soup for eliminating blood stasis and reducing jaundice |
| 01/08/2014 | CN101600457B Anti-il-13 antibody formulations and uses thereof |
| 01/08/2014 | CN101516335B Formulations for benzimidazolyl pyridyl ethers |
| 01/08/2014 | CN101489538B Oral preparation comprising pioglitazone |
| 01/08/2014 | CN101466385B Delayed-release glucocorticoid treatment of rheumatoid disease |
| 01/07/2014 | US8623938 Inkjet ink and method for making the same |
| 01/07/2014 | US8623922 Bronchodilating Beta-agonist compositions and methods |
| 01/07/2014 | US8623868 Processes of making and using pharmaceutical formulations of antineoplastic agents |
| 01/07/2014 | US8623851 Formoterol/steroid bronchodilating compositions and methods of use thereof |
| 01/07/2014 | US8623839 Compositions and methods for stabilized polysaccharide formulations |
| 01/07/2014 | US8623833 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 01/07/2014 | US8623826 Compositions and methods for treating centrally mediated nausea and vomiting |
| 01/07/2014 | US8623431 Composition to enhance the bioavailability of curcumin |
| 01/07/2014 | US8623419 Technology for preparation of macromolecular microspheres |
| 01/07/2014 | US8623418 Pharmaceutical composition |
| 01/07/2014 | US8623417 Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same |
| 01/07/2014 | US8623416 Formulations comprising aminosterols |
| 01/07/2014 | US8623415 Method for producing biologically ingestible microparticles, biologically ingestible microparticles, and dispersion and pharmaceutical composition containing the same |
| 01/07/2014 | US8623414 Compositions comprising a lipid and copolymer of styrene and maleic acid |
| 01/07/2014 | US8623413 Compositions and medical devices utilizing bioabsorbable liquid polymers |
| 01/07/2014 | US8623412 Abuse-resistant pharmaceutical compositions |
| 01/07/2014 | US8623411 Modified release compositions comprising tacrolimus |
| 01/07/2014 | US8623410 Modified release compositions comprising tacrolimus |
| 01/07/2014 | US8623409 Clonidine formulation |
| 01/07/2014 | US8623408 Cladribine formulations for improved oral and transmucosal delivery |
| 01/07/2014 | US8623407 Gabapentin-containing solid compositions and process for preparing the same |
| 01/07/2014 | US8623406 Stable pharmaceutical composition and methods of using same |
| 01/07/2014 | US8623405 Finely divided composition containing poorly water soluble substance |
| 01/07/2014 | US8623401 Wafer formulation |
| 01/07/2014 | US8623400 Drug-carrying contact lens and method for fabricating the same |
| 01/07/2014 | US8623399 Methods of producing mesoporous drug delivery implants |
| 01/07/2014 | US8623396 Compositions and methods for delivering clonidine and bupivacaine to a target tissue site |
| 01/07/2014 | US8623388 Denture care composition |
| 01/07/2014 | US8623387 External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
| 01/07/2014 | US8623385 Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein |
| 01/07/2014 | US8623352 Stabilized liquid and lyophilized ADAMTS13 formulations |
| 01/07/2014 | US8623347 Antiviral drugs for treatment of arenavirus infection |
| 01/07/2014 | US8623339 Hair bleaching composition and method for producing same |
| 01/07/2014 | US8623332 Chewing gum having sustained release of nicotine |
| 01/07/2014 | US8623331 Compressed chewing gum tablet |
| 01/07/2014 | US8623330 Emollient foams for treatment of seborrheic dermatitis |
| 01/07/2014 | US8623329 Method for the treatment of lung tumors |
| 01/07/2014 | US8623323 Thickened beverages for dysphagia |
| 01/07/2014 | US8622998 Automated catheter length determination for implantable fluid delivery device |
| 01/07/2014 | CA2763775C Bisphosphonic acids for the treatment and prevention of osteoporosis |
| 01/07/2014 | CA2716838C Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same |
| 01/07/2014 | CA2694408C Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
| 01/07/2014 | CA2636618C Oral s-adenosylmethionine compositions |
| 01/07/2014 | CA2629988C Pharmaceutical composition for the treatment of acute disorders |
| 01/07/2014 | CA2611909C Composition for treatment of corneal disease |
| 01/07/2014 | CA2584980C Reverse micelles based on phytosterols and acylglycerols and therapeutic uses thereof |
| 01/07/2014 | CA2582096C Conveniently implantable sustained release drug compositions |
| 01/07/2014 | CA2546675C Pharmaceutical formulations for the sustained release of one or more active principles and applications thereof, such as therapeutic applications |
| 01/07/2014 | CA2514650C Use of edible acids in fast-dispersing pharmaceutical solid dosage forms |
| 01/07/2014 | CA2396938C Delivering substances to invertebrate organisms |
| 01/03/2014 | WO2014005107A2 Microparticle formulations for delivery to the upper and central respiratory tract and methods of manufacture |
| 01/03/2014 | WO2014005103A2 Microparticle formulations for delivery to the lower and central respiratory tract and methods of manufacture |
| 01/03/2014 | WO2014005032A1 Racecadotril lipid compositions |
| 01/03/2014 | WO2014005021A1 Racecadotril liquid compositions |
| 01/03/2014 | WO2014004912A1 Methods and devices for ultrasound contrast-assisted therapy |
| 01/03/2014 | WO2014004895A1 Stable formulations for parenteral injection of small molecule drugs |
| 01/03/2014 | WO2014004707A1 Formulations comprising ibrutinib |
| 01/03/2014 | WO2014004578A1 Temperature stable vaccine formulations |
| 01/03/2014 | WO2014003957A1 Medical dressing with multiple adhesives |
| 01/03/2014 | WO2014003874A1 Method to enhance swallowing safety and appeal of beverages for treating dysphagia based on rheological and sensory parameters |
| 01/03/2014 | WO2014003834A1 Method of stably treating incontinence using a bulking agent |
| 01/03/2014 | WO2014003810A1 Fenofibrate formulation |
| 01/03/2014 | WO2014003706A1 Fenofibrate formulation |
| 01/03/2014 | WO2014003678A1 Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil |
| 01/03/2014 | WO2014003677A1 Pharmaceutical compositions comprising solid dispersion particles containing tadalafil |
| 01/03/2014 | WO2014003634A1 Emulsifier system in the form of a paste |
| 01/03/2014 | WO2014003454A1 Oral dosage form product of clopidogrel hydrogen sulfate with improved stability |
| 01/03/2014 | WO2014003400A1 Aripiprazole-organic acid cocrystal, preparation or composition containing same, and preparation method therefor |
| 01/03/2014 | WO2014003371A1 Immediate-release and sustained-release pharmaceutical composition comprising acebrophylline |
| 01/03/2014 | WO2014003307A1 Artificial saliva composition comprising hyaluronic acid |
| 01/03/2014 | WO2014003305A1 Pharmaceutical composition containing fimasartan and hydrochlorothiazide |
| 01/03/2014 | WO2014003199A1 Liquid preparations of amines and organic acids stabilized by salts |
| 01/03/2014 | WO2014003015A1 Dispersion liquid and hydrogel formation method |
| 01/03/2014 | WO2014003008A1 Novel histamine liberator contained in human sweat |
| 01/03/2014 | WO2014002851A1 Solid pharmaceutical tablet and method for producing same |
| 01/03/2014 | WO2014002599A1 Crude-drug-containing pharmaceutical composition |
| 01/03/2014 | WO2014002553A1 Aripiprazole oral pharmaceutical preparation |
| 01/03/2014 | WO2014002108A1 A core-shell nanostructure on the basis of proteins with corresponding therapeutic agents |
| 01/03/2014 | WO2014002042A1 Injectable supersaturated acetaminophen solution for spinal administration |
| 01/03/2014 | WO2014002015A1 Pharmaceutical composition comprising dutasteride |
| 01/03/2014 | WO2014002011A1 Micronized particles of olmesartan medoxomil and pharmaceutical composition thereof |
| 01/03/2014 | WO2014001889A1 Angiotensin converting enzyme inhibitors for treating optic neuropathy or congenital optic atrophy |
| 01/03/2014 | WO2014001268A1 Pharmaceutical form for extended release of active substances |
| 01/03/2014 | WO2014001267A2 Medicament form for release of active ingredients |
| 01/03/2014 | WO2014001153A1 Colouring compositions suitable for human consumption |
| 01/03/2014 | WO2014001132A1 Method for the therapeutic treatment of keratinous substrate, mucous membrane or tooth |